Showing results (211-220 of 263) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trialsNicolas Boissel, Marie-Françoise Auclerc, Véronique Lhéritier, et al.Transplantation and Cellular Therapy|September 15, 2022
Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric StudyGrégoire Le Meur, Adriana Plesa, Marie-Virginie Larcher, et al.Blood|September 20, 2002
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trialHervé Dombret, Jean Gabert, Jean-Michel Boiron, et al.Blood|January 15, 2015
Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemiaNathalie Dhédin, Anne Huynh, Sébastien Maury, et al.Leukemia Research|February 14, 2015
The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcomeWei W Chien, Régine Catallo, Amel Chebel, et al.American Journal of Hematology|July 28, 2015
Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experienceMarie-Anne Couturier, Françoise Huguet, Patrice Chevallier, et al.Haematologica|December 8, 2018
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotypeFrédéric Baron, Marian Stevens-Kroef, Michal Kicinski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2017
Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First RemissionXavier Thomas, Stéphane de Botton, Sylvie Chevret, et al.Blood Advances|January 17, 2024
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trialGail J Roboz, Guillermo Sanz, Elizabeth A Griffiths, et al.Annals of Hematology|June 22, 2018
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trialsFrédéric Baron, Marian Stevens-Kroef, Michal Kicinski, et al.Pageof 27